https://news.medxy.ai/ngs-flt3-itd-mrd-aml/Medxy AIen2026-08-15T13:57:20-07:00ELN‑DAVID technical recommendations: NGS-based FLT3‑ITD MRD testing in AML — what clinicians and labs need to know https://news.medxy.ai/ja/genetic-risk-mental-illness/Medxy AIja2026-08-15T11:57:43-07:00スウェーデン登録データが示す精神疾患の遺伝的リスク構造 https://news.medxy.ai/vi/genetic-risk-psych-disorders-sweden/Medxy AIvi2026-08-15T11:57:23-07:00Cấu trúc nguy cơ di truyền của các rối loạn tâm thần trong các cơ sở đăng ký dựa trên quần thể ở Thụy Điển https://news.medxy.ai/ja/psychotropic-prescriptions-us/Medxy AIja2026-08-15T11:56:24-07:00重症疾患後の精神作用薬処方、診断の裏付けなく行われることが多い米国成人での実態 https://news.medxy.ai/vi/prescription-psychotropic-effects/Medxy AIvi2026-08-15T11:56:06-07:00Kê đơn thuốc tác động lên tâm thần sau bệnh nặng ở người lớn Mỹ: nhiều trường hợp thiếu chẩn đoán hỗ trợ được ghi nhận https://news.medxy.ai/zh/diabetes-management-training/Medxy AIzh2026-08-15T11:55:16-07:00内科住院医师糖尿病管理能力提升：体验式与传统连续葡萄糖监测课程之比较 https://news.medxy.ai/ja/diabetes-training-comparison/Medxy AIja2026-08-15T11:55:02-07:00内科レジデントの糖尿病診療能力を高める：体験型と従来型のcontinuous glucose monitoringカリキュラムの比較 https://news.medxy.ai/vi/diabetes-care-training/Medxy AIvi2026-08-15T11:54:44-07:00Tăng cường năng lực chăm sóc đái tháo đường cho bác sĩ nội trú Nội khoa: So sánh chương trình CGM dựa trên trải nghiệm với chương trình truyền thống https://news.medxy.ai/ja/medicare-advantage-diabetes/Medxy AIja2026-08-15T11:53:18-07:00Medicare Advantageは2型糖尿病の転帰を改善できるか：費用増大のなかで臨床面と社会面の影響を検証する https://news.medxy.ai/zh/team-beam-preprocessing/Medxy AIzh2026-08-15T11:51:27-07:00TEAM 与 BEAM 预处理方案在淋巴瘤自体移植中的疗效与安全性比较：综合综述 https://news.medxy.ai/ja/team-vs-beam-review/Medxy AIja2026-08-15T11:51:12-07:00リンパ腫に対する自家移植でのTEAMとBEAM前処置の比較：安全性・有効性をめぐる包括的レビュー https://news.medxy.ai/vi/team-beam-lymphoma/Medxy AIvi2026-08-15T11:50:54-07:00TEAM hay BEAM trong phác đồ chuẩn bị ghép tự thân cho lymphoma: Tổng quan toàn diện về hiệu quả và độ an toàn https://news.medxy.ai/vi/eln-david-mrd-testing/Medxy AIvi2026-08-15T11:40:06-07:00Khuyến nghị kỹ thuật ELN‑DAVID: xét nghiệm MRD FLT3‑ITD dựa trên NGS trong AML — điều bác sĩ và phòng xét nghiệm cần biết https://news.medxy.ai/zh/flt3-itd-mrd-testing/Medxy AIzh2026-08-15T11:39:38-07:00ELN‑DAVID技术建议：AML中基于NGS的FLT3‑ITD MRD检测——临床医生与实验室必须了解的要点 https://news.medxy.ai/zh/long-term-safety-17a-hydroxyprogesterone/Medxy AIzh2026-08-15T10:19:38-07:00双胎宫内暴露17-α-羟孕酮己酸酯的长期安全性：一项14年随访研究 https://news.medxy.ai/ja/twin-pregnancy-safety/Medxy AIja2026-08-15T10:19:24-07:00双胎妊娠における出生前17-alpha-hydroxyprogesterone caproateの長期安全性：14年追跡研究 https://news.medxy.ai/vi/long-term-safety-17alpha-hydroxyprogesterone/Medxy AIvi2026-08-15T10:19:07-07:00An toàn dài hạn của 17-alpha-hydroxyprogesterone caproate trước sinh ở song thai: Nghiên cứu theo dõi 14 năm https://news.medxy.ai/long-term-safety-of-prenatal-17-alpha-hydroxyprogesterone-caproate-in-twins-a-14-year-follow-up-study/Medxy AIen2026-08-15T10:18:12-07:00Long-Term Safety of Prenatal 17-Alpha-Hydroxyprogesterone Caproate in Twins: A 14-Year Follow-Up Study https://news.medxy.ai/zh/ultrasound-assisted-labor/Medxy AIzh2026-08-15T10:17:53-07:00产时超声助力难产管理：优化产科决策的新工具 https://news.medxy.ai/vi/obstetric-decision-ultrasound/Medxy AIvi2026-08-15T10:17:15-07:00Nâng cao quyết định sản khoa: Vai trò của siêu âm trong chuyển dạ trong xử trí chuyển dạ khó https://news.medxy.ai/enhancing-obstetric-decision-making-the-role-of-intrapartum-sonography-in-managing-difficult-labor/Medxy AIen2026-08-15T10:16:17-07:00Enhancing Obstetric Decision-Making: The Role of Intrapartum Sonography in Managing Difficult Labor https://news.medxy.ai/ja/menopause-hormone-therapy-cost-benefit/Medxy AIja2026-08-15T10:15:40-07:00閉経ホルモン療法の費用対効果を読み解く――リスク・ベネフィットと経済モデルの統合評価 https://news.medxy.ai/cost-effectiveness-analysis-of-menopausal-hormone-therapy-integrating-risk-benefit-profiles-and-economic-models/Medxy AIen2026-08-15T10:14:00-07:00Cost-Effectiveness Analysis of Menopausal Hormone Therapy: Integrating Risk-Benefit Profiles and Economic Models https://news.medxy.ai/zh/swe-vcte-masld-risk/Medxy AIzh2026-08-15T10:13:41-07:00SWE 与 VCTE 在 MASLD 风险分层中的表现比较：基于 FIB-4 两步算法的研究解读 https://news.medxy.ai/ja/masld-risk-comparison/Medxy AIja2026-08-15T10:13:25-07:00MASLDリスク層別化におけるSWEとVCTEの比較：FIB-4に基づく二段階アルゴリズムからの知見 https://news.medxy.ai/comparative-effectiveness-of-shear-wave-elastography-and-vcte-in-masld-risk-stratification-insights-from-fib-4-based-two-step-algorithms/Medxy AIen2026-08-15T10:12:25-07:00Comparative Effectiveness of Shear Wave Elastography and VCTE in MASLD Risk Stratification: Insights from FIB-4-Based Two-Step Algorithms https://news.medxy.ai/cryptogenic-steatotic-liver-disease-a-lean-phenotype-linked-to-increased-liver-related-mortality/Medxy AIen2026-08-15T10:11:20-07:00Cryptogenic Steatotic Liver Disease: A Lean Phenotype Linked to Increased Liver-Related Mortality https://news.medxy.ai/zh/neurotransmitter-connectome-damage/Medxy AIzh2026-08-15T10:11:03-07:00神经递质引导的连接组破坏：揭示卒中后语言障碍的新关键 https://news.medxy.ai/ja/neurotransmitter-guided-connectome-disruption-to-poststroke-language-impairment/Medxy AIja2026-08-15T10:10:47-07:00神経伝達物質に規定されるコネクトーム障害：脳卒中後の言語障害の鍵 https://news.medxy.ai/vi/connectome-neurotransmitter-stroke/Medxy AIvi2026-08-15T10:10:30-07:00Rối loạn connectome được dẫn hướng bởi neurotransmitter: chìa khóa giải thích suy giảm ngôn ngữ sau đột quỵ https://news.medxy.ai/neurotransmitter-guided-connectome-disruption-as-a-key-to-poststroke-language-impairment/Medxy AIen2026-08-15T10:09:32-07:00Neurotransmitter-Guided Connectome Disruption as a Key to Poststroke Language Impairment https://news.medxy.ai/zh/acute-intracerebral-hemorrhage-dwi/Medxy AIzh2026-08-15T10:09:15-07:00急性脑内出血中的DWI阳性病灶：脑小血管病与预后的新认识 https://news.medxy.ai/ja/dwi-brain-hemorrhage/Medxy AIja2026-08-15T10:08:59-07:00急性脳内出血におけるDWI陽性病変：脳小血管病と予後を読み解く https://news.medxy.ai/vi/positive-dwi-brain-bleed/Medxy AIvi2026-08-15T10:08:40-07:00Tổn thương DWI dương tính trong xuất huyết não cấp: Gợi ý về bệnh lý mạch máu nhỏ não và tiên lượng https://news.medxy.ai/dwi-positive-lesions-in-acute-intracerebral-hemorrhage-insights-into-cerebral-small-vessel-disease-and-prognosis/Medxy AIen2026-08-15T10:08:00-07:00DWI-Positive Lesions in Acute Intracerebral Hemorrhage: Insights into Cerebral Small Vessel Disease and Prognosis https://news.medxy.ai/ja/plasma-biomarker-tau/Medxy AIja2026-08-15T10:07:42-07:00大脳新皮質タウ負荷を捉える血漿バイオマーカー https://news.medxy.ai/vi/tau-burden-biomarker/Medxy AIvi2026-08-15T10:07:24-07:00Dấu ấn sinh học huyết tương dự báo gánh nặng tau tân vỏ não https://news.medxy.ai/plasma-biomarkers-for-neocortical-tau-burden/Medxy AIen2026-08-15T10:06:28-07:00Plasma Biomarkers for Neocortical Tau Burden https://news.medxy.ai/zh/latin-america-thyroid-cancer/Medxy AIzh2026-08-15T10:06:09-07:00拉丁美洲低风险乳头状甲状腺癌热消融研究：多中心数据带来令人鼓舞的早期结果 https://news.medxy.ai/ja/low-risk-thyroid-cancer-therapy/Medxy AIja2026-08-15T10:05:51-07:00ラテンアメリカにおける低リスク乳頭甲状腺癌への熱焼灼療法：多施設研究が示した有望な初期成績 https://news.medxy.ai/vi/thermal-ablation-thyroid-cancer/Medxy AIvi2026-08-15T10:05:29-07:00Đốt nhiệt trong ung thư biểu mô nhú tuyến giáp nguy cơ thấp ở Mỹ Latinh: Kết quả sớm đầy hứa hẹn từ nghiên cứu đa trung tâm https://news.medxy.ai/thermal-ablation-for-low-risk-papillary-thyroid-cancer-in-latin-america-promising-early-outcomes-from-a-multicenter-study/Medxy AIen2026-08-15T10:04:02-07:00Thermal Ablation for Low-Risk Papillary Thyroid Cancer in Latin America: Promising Early Outcomes from a Multicenter Study https://news.medxy.ai/zh/arginine-availability-hyperglycemia/Medxy AIzh2026-08-15T10:03:45-07:00高血糖下精氨酸可利用性下降：A-β+酮症倾向性糖尿病的独特代谢特征与酮症酸中毒风险 https://news.medxy.ai/ja/arginine-utilization-diabetes/Medxy AIja2026-08-15T10:03:30-07:00A-β+ ケトーシス傾向糖尿病におけるアルギニン利用能低下：ケトアシドーシスリスクを規定する特異的代謝シグネチャー https://news.medxy.ai/vi/arginine-deficiency-diabetes/Medxy AIvi2026-08-15T10:03:13-07:00Giảm khả dụng arginine trong đái tháo đường nhiễm ceton dễ xuất hiện A-β+: Dấu ấn chuyển hóa đặc trưng liên quan nguy cơ nhiễm toan ceton https://news.medxy.ai/arginine-bioavailability-diabetes/Medxy AIen2026-08-15T10:02:13-07:00Diminished Arginine Bioavailability in A-β+ Ketosis-Prone Diabetes: A Distinct Metabolic Signature Underlying Ketoacidosis Risk https://news.medxy.ai/zh/subclinical-hypothyroidism-treatment/Medxy AIzh2026-08-15T10:01:54-07:00老年亚临床甲状腺功能减退症中左甲状腺素治疗与心代谢生物标志物：综合综述 https://news.medxy.ai/ja/levothyroxine-heart-metabolism/Medxy AIja2026-08-15T10:01:36-07:00高齢の潜在性甲状腺機能低下症におけるレボチロキシン治療と心代謝バイオマーカー：包括的レビュー https://news.medxy.ai/vi/levothyroxine-treatment-and-cardiometabolic-biomarkers-in-older-adults-with-subclinical-hypothyroidism/Medxy AIvi2026-08-15T10:01:16-07:00Điều trị bằng Levothyroxine và các dấu ấn sinh học tim-chuyển hóa ở người cao tuổi mắc suy giáp cận lâm sàng https://news.medxy.ai/levothyroxine-treatment-and-cardiometabolic-biomarkers-in-older-adults-with-subclinical-hypothyroidism-a-comprehensive-review/Medxy AIen2026-08-15T09:59:35-07:00Levothyroxine Treatment and Cardiometabolic Biomarkers in Older Adults with Subclinical Hypothyroidism: A Comprehensive Review https://news.medxy.ai/ja/housing-instability-diabetes/Medxy AIja2026-08-15T09:59:09-07:00住居不安定性は、コントロール不良糖尿病成人の費用関連治療中断と経済的困難に関連する https://news.medxy.ai/vi/housing-instability-diabetes-2/Medxy AIvi2026-08-15T09:58:51-07:00Bất ổn về nhà ở liên quan đến không tuân thủ điều trị do chi phí và khó khăn tài chính ở người lớn mắc đái tháo đường kiểm soát kém https://news.medxy.ai/housing-instability-linked-to-cost-related-medication-nonadherence-and-financial-hardship-in-adults-with-uncontrolled-diabetes/Medxy AIen2026-08-15T09:57:57-07:00Housing Instability Linked to Cost-Related Medication Nonadherence and Financial Hardship in Adults with Uncontrolled Diabetes https://news.medxy.ai/zh/weekly-icosa-vs-insulin-u100/Medxy AIzh2026-08-15T09:57:36-07:00每周一次IcoSema对比每日甘精胰岛素U100用于2型糖尿病：来自COMBINE 4 3b期试验及相关进展的证据 https://news.medxy.ai/ja/type-2-diabetes-treatment-2/Medxy AIja2026-08-15T09:57:12-07:002型糖尿病における週1回IcoSemaと毎日投与グラルギンU100：COMBINE 4第3b相試験のエビデンスと関連する最新知見 https://news.medxy.ai/vi/once-weekly-icosema-versus-daily-insulin-glargine-u100-in-type-2-diabetes/Medxy AIvi2026-08-15T09:56:50-07:00So sánh IcoSema dùng một lần mỗi tuần với Insulin Glargine U100 dùng hàng ngày ở bệnh nhân đái tháo đường tuýp 2: Bằng chứng từ thử nghiệm lâm sàng giai đoạn 3b COMBINE 4 và các tiến bộ liên quan https://news.medxy.ai/once-weekly-icosema-versus-daily-insulin-glargine-u100-in-type-2-diabetes-evidence-from-the-combine-4-phase-3b-trial-and-related-advances/Medxy AIen2026-08-15T09:55:12-07:00Once-weekly IcoSema versus Daily Insulin Glargine U100 in Type 2 Diabetes: Evidence from the COMBINE 4 Phase 3b Trial and Related Advances https://news.medxy.ai/zh/hf-risk-stratification/Medxy AIzh2026-08-15T09:54:55-07:00心衰房间隔分流治疗如何精准选人？RELIEVE-HF试验揭示个体化风险分层 https://news.medxy.ai/ja/atrial-shunt-risk-modeling/Medxy AIja2026-08-15T09:54:38-07:00心不全における心房間シャント治療の個別化リスクモデリング：RELIEVE-HF試験から得られた知見 https://news.medxy.ai/vi/shunt-therapy-risk-model/Medxy AIvi2026-08-15T09:54:17-07:00Mô hình hóa nguy cơ cá thể hóa trong liệu pháp shunt liên nhĩ ở suy tim: Góc nhìn từ thử nghiệm RELIEVE-HF https://news.medxy.ai/personalized-risk-modeling-of-interatrial-shunt-therapy-in-heart-failure-insights-from-the-relieve-hf-trial/Medxy AIen2026-08-15T09:53:24-07:00Personalized Risk Modeling of Interatrial Shunt Therapy in Heart Failure: Insights from the RELIEVE-HF Trial https://news.medxy.ai/zh/angina-patients-with-myocardial-bridge-and-non-obstructive-coronary-arteries/Medxy AIzh2026-08-15T09:53:04-07:00伴心肌桥及非阻塞性冠状动脉病变的稳定型心绞痛患者接受外科“去顶术”的远期获益 https://news.medxy.ai/ja/surgical-unroofing-in-angina-patients-with-myocardial-bridge-and-non-obstructive-coronary-arteries/Medxy AIja2026-08-15T09:52:48-07:00心筋ブリッジおよび非閉塞性冠動脈を有する狭心症患者における外科的筋束切除術の長期成績 https://news.medxy.ai/vi/benefits-of-surgical-unroofing-in-angina-patients-with-myocardial-bridge-and-non-obstructive-coronary-arteries/Medxy AIvi2026-08-15T09:52:29-07:00Lợi ích dài hạn của phẫu thuật mở mái ở bệnh nhân đau thắt ngực có cầu cơ tim và động mạch vành không bị tắc nghẽn https://news.medxy.ai/long-term-benefits-of-surgical-unroofing-in-angina-patients-with-myocardial-bridge-and-non-obstructive-coronary-arteries/Medxy AIen2026-08-15T09:51:18-07:00Long-Term Benefits of Surgical Unroofing in Angina Patients with Myocardial Bridge and Non-Obstructive Coronary Arteries https://news.medxy.ai/zh/acute-effects-cannabis/Medxy AIzh2026-08-15T09:51:01-07:00吸入大麻对心脏异位搏动、运动、睡眠与血糖的急性影响：临床证据与机制认识的综合解读 https://news.medxy.ai/ja/cannabis-acute-effects/Medxy AIja2026-08-15T09:50:43-07:00大麻吸入の急性影響：心臓性期外収縮、身体活動、睡眠、血糖をめぐる臨床エビデンスと機序的知見の統合 https://news.medxy.ai/vi/acute-cannabis-effects/Medxy AIvi2026-08-15T09:50:23-07:00Tác động cấp tính của hít cannabis lên ngoại tâm thu tim, hoạt động thể lực, giấc ngủ và glucose: Tổng hợp bằng chứng lâm sàng và cơ chế https://news.medxy.ai/acute-effects-of-cannabis-inhalation-on-cardiac-ectopy-physical-activity-sleep-and-glucose-a-synthesis-of-clinical-evidence-and-mechanistic-insights/Medxy AIen2026-08-15T09:49:03-07:00Acute Effects of Cannabis Inhalation on Cardiac Ectopy, Physical Activity, Sleep, and Glucose: A Synthesis of Clinical Evidence and Mechanistic Insights https://news.medxy.ai/zh/prostate-cancer-metabolism/Medxy AIzh2026-08-15T09:48:40-07:00前列腺癌启动雄激素受体通路抑制剂后代谢紊乱：临床意义与风险 https://news.medxy.ai/ja/androgen-receptor-inhibitors/Medxy AIja2026-08-15T09:48:23-07:00前立腺癌におけるアンドロゲン受容体経路阻害薬導入後の代謝異常：臨床的意義とリスク https://news.medxy.ai/vi/metabolic-disorders-prostate-cancer/Medxy AIvi2026-08-15T09:48:00-07:00Rối loạn chuyển hóa sau khi khởi trị thuốc ức chế đường truyền tín hiệu thụ thể androgen ở ung thư tuyến tiền liệt: ý nghĩa lâm sàng và nguy cơ https://news.medxy.ai/metabolic-dysfunction-following-initiation-of-androgen-receptor-pathway-inhibitors-in-prostate-cancer-clinical-implications-and-risks/Medxy AIen2026-08-15T09:46:53-07:00Metabolic Dysfunction Following Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer: Clinical Implications and Risks https://news.medxy.ai/early-features-multiple-endocrine-neoplasia/Medxy AIen2026-08-14T20:48:01-07:00Extra-Endocrine Features in Infancy as Early Clues to Multiple Endocrine Neoplasia Type 2B: A Case Series from Bambino Gesù Children’s Hospital https://news.medxy.ai/zh/pediatric-cardiac-arrest-decisions/Medxy AIzh2026-08-14T20:47:26-07:00儿童院外心搏骤停中复苏徒劳与终止决策：EMS机构间差异显著 https://news.medxy.ai/ja/pediatric-ems-variation/Medxy AIja2026-08-14T20:47:06-07:00小児院外心停止における蘇生中止判断の機関差――EMSのばらつきが示す臨床的課題 https://news.medxy.ai/vi/variability-in-futility-determinations-and-termination-of-resuscitation-for-pediatric-out-of-hospital-cardiac-arrest/Medxy AIvi2026-08-14T20:46:46-07:00Sự khác biệt giữa các đơn vị trong việc xác định tính vô ích và chấm dứt hồi sức đối với trẻ em bị ngừng tuần hoàn ngoài bệnh viện https://news.medxy.ai/agency-level-variability-in-futility-determinations-and-termination-of-resuscitation-for-pediatric-out-of-hospital-cardiac-arrest/Medxy AIen2026-08-14T20:45:51-07:00Agency-Level Variability in Futility Determinations and Termination of Resuscitation for Pediatric Out-of-Hospital Cardiac Arrest https://news.medxy.ai/ja/metastatic-castration-resistant-prostate-cancer/Medxy AIja2026-08-14T20:39:44-07:00転移性去勢抵抗性前立腺癌の全身治療：ASCO living guideline（2026.1.4版）の重要推奨 https://news.medxy.ai/vi/prostate-cancer-2026/Medxy AIvi2026-08-14T20:39:10-07:00Ung thư tuyến tiền liệt kháng thiến di căn: khuyến nghị then chốt từ Hướng dẫn sống ASCO về điều trị toàn thân (Phiên bản 2026.1.4) https://news.medxy.ai/zh/preterm-enteral-feeding/Medxy AIzh2026-08-14T20:39:06-07:00早产儿早期纯肠内喂养：荟萃分析评估其安全性与获益 https://news.medxy.ai/ja/early-enteral-nutrition/Medxy AIja2026-08-14T20:38:45-07:00早産児の早期完全経腸栄養：メタ解析でみる安全性と有用性 https://news.medxy.ai/zh/metastatic-castration-resistant-prostate-cancer-treatment/Medxy AIzh2026-08-14T20:38:34-07:00转移性去势抵抗性前列腺癌的全身治疗：ASCO 活指南（2026.1.4版）核心推荐 https://news.medxy.ai/vi/enteral-feeding-preterms/Medxy AIvi2026-08-14T20:38:25-07:00Nuôi ăn hoàn toàn qua đường ruột sớm ở trẻ sinh non: Đánh giá độ an toàn và lợi ích qua phân tích gộp https://news.medxy.ai/early-exclusive-enteral-feeding-in-preterm-infants-assessing-safety-and-benefits-through-meta-analysis/Medxy AIen2026-08-14T20:37:35-07:00Early Exclusive Enteral Feeding in Preterm Infants: Assessing Safety and Benefits through Meta-Analysis https://news.medxy.ai/systemic-therapy-for-metastatic-castration-resistant-prostate-cancer-key-recommendations-from-the-asco-living-guideline-version-2026-1-4/Medxy AIen2026-08-14T20:34:27-07:00Systemic Therapy for Metastatic Castration-Resistant Prostate Cancer: Key Recommendations from the ASCO Living Guideline (Version 2026.1.4) https://news.medxy.ai/zh/trastuzumab-therapy-salivary-cancer/Medxy AIzh2026-08-14T20:28:30-07:00曲妥珠单抗瑞泽替康用于晚期唾液腺癌：HER2 不同表达水平下均显示出令人期待的疗效 https://news.medxy.ai/ja/trastuzumab-rezetakan/Medxy AIja2026-08-14T20:27:18-07:00HER2発現を問わず有望な効果：進行唾液腺癌におけるトラスツズマブ レゼテカン https://news.medxy.ai/vi/trastuzumab-rezetecan-her2/Medxy AIvi2026-08-14T20:27:00-07:00Trastuzumab Rezetecan trong ung thư biểu mô tuyến nước bọt tiến triển: Hiệu quả đầy hứa hẹn ở nhiều mức biểu hiện HER2 https://news.medxy.ai/trastuzumab-rezetecan-in-advanced-salivary-gland-carcinoma-promising-efficacy-across-her2-expression-levels/Medxy AIen2026-08-14T20:26:13-07:00Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma: Promising Efficacy Across HER2 Expression Levels https://news.medxy.ai/zh/clinical-insights-lipoprotein-deposition/Medxy AIzh2026-08-14T08:33:33-07:00类脂质蛋白沉积症的临床洞察：显微喉外科的疗效与长期结局 https://news.medxy.ai/ja/lipoproteinemia-clinical-findings/Medxy AIja2026-08-14T08:33:05-07:00脂質蛋白症の臨床的知見：マイクロ喉頭手術の有効性と長期転帰 https://news.medxy.ai/vi/lipoid-proteinosis-outcome/Medxy AIvi2026-08-14T08:32:45-07:00Lipoid Proteinosis: Hiệu quả và kết cục dài hạn của microlaryngosurgery https://news.medxy.ai/clinical-insights-into-lipoid-proteinosis-efficacy-and-long-term-outcomes-of-microlaryngosurgery/Medxy AIen2026-08-14T08:31:03-07:00Clinical Insights into Lipoid Proteinosis: Efficacy and Long-Term Outcomes of Microlaryngosurgery https://news.medxy.ai/zh/robotic-vs-laparoscopic-hysterectomy/Medxy AIzh2026-08-14T08:29:39-07:00用客观工具验证机器人与腹腔镜子宫切除术表现：外科卓越迈向标准化 https://news.medxy.ai/ja/robotic-laparoscopic-hysterectomy/Medxy AIja2026-08-14T08:29:24-07:00ロボット支援下・腹腔鏡下子宮摘出術の手術成績を可視化する客観的評価ツールの有用性が明らかに https://news.medxy.ai/vi/robotic-hysterectomy-tools/Medxy AIvi2026-08-14T08:29:02-07:00Nâng tầm phẫu thuật phụ khoa: Công cụ khách quan xác thực hiệu quả trong cắt tử cung hỗ trợ bằng robot và nội soi https://news.medxy.ai/advancing-surgical-excellence-an-objective-tool-validates-performance-in-robotic-and-laparoscopic-hysterectomy/Medxy AIen2026-08-14T08:27:38-07:00Advancing Surgical Excellence: An Objective Tool Validates Performance in Robotic and Laparoscopic Hysterectomy https://news.medxy.ai/zh/adult-adrenal-leukodystrophy/Medxy AIzh2026-08-14T08:25:02-07:00成人脑型肾上腺脑白质营养不良病灶进展的解析：为个体化管理提供依据 https://news.medxy.ai/vi/adrenoleukodystrophy-progress/Medxy AIvi2026-08-14T08:24:17-07:00Giải mã tiến triển tổn thương trong adrenoleukodystrophy thể não ở người lớn để định hướng quản lý cá thể hóa https://news.medxy.ai/unraveling-lesion-progression-in-adult-cerebral-adrenoleukodystrophy-to-inform-personalized-management/Medxy AIen2026-08-14T08:22:45-07:00Unraveling Lesion Progression in Adult Cerebral Adrenoleukodystrophy to Inform Personalized Management https://news.medxy.ai/zh/electrical-stimulation-pelvic-training/Medxy AIzh2026-08-14T08:21:54-07:00电刺激生物反馈联合盆底肌训练：产后盆腔器官脱垂长期疗效如何？ https://news.medxy.ai/ja/postpartum-pelvic-floor/Medxy AIja2026-08-14T08:21:26-07:00産後骨盤臓器脱に対する電気刺激バイオフィードバック併用骨盤底筋訓練の長期効果を検証する https://news.medxy.ai/vi/long-term-impact-of-electrical-stimulation-biofeedback-combined-with-pelvic-floor-muscle-training-for-postpartum-pelvic-organ-prolapse/Medxy AIvi2026-08-14T08:19:15-07:00Đánh giá tác động dài hạn của phương pháp phản hồi sinh học kết hợp kích thích điện và tập luyện cơ sàn chậu đối với tình trạng sa tạng chậu sau sinh https://news.medxy.ai/evaluating-the-long-term-impact-of-electrical-stimulation-biofeedback-combined-with-pelvic-floor-muscle-training-for-postpartum-pelvic-organ-prolapse/Medxy AIen2026-08-14T08:17:38-07:00Evaluating the Long-Term Impact of Electrical Stimulation Biofeedback Combined with Pelvic Floor Muscle Training for Postpartum Pelvic Organ Prolapse https://news.medxy.ai/zh/her2-status-reassessment/Medxy AIzh2026-08-14T08:17:08-07:00复发性宫颈癌中HER2状态再评估：动态表达对靶向治疗的临床意义 https://news.medxy.ai/ja/her2-status-cervical-cancer/Medxy AIja2026-08-14T08:16:50-07:00再発子宮頸癌における HER2 状態を再考する：動的発現が示す分子標的治療への臨床的含意 https://news.medxy.ai/vi/her2-cervical-cancer/Medxy AIvi2026-08-14T08:16:32-07:00Tình trạng HER2 ở ung thư cổ tử cung tái phát: Ý nghĩa lâm sàng của sự biến thiên biểu hiện đối với điều trị nhắm đích https://news.medxy.ai/revisiting-her2-status-in-recurrent-cervical-cancer-clinical-implications-of-dynamic-expression-for-targeted-therapy/Medxy AIen2026-08-14T08:13:19-07:00Revisiting HER2 Status in Recurrent Cervical Cancer: Clinical Implications of Dynamic Expression for Targeted Therapy https://news.medxy.ai/zh/inebilizumab-mg-study/Medxy AIzh2026-08-14T08:12:58-07:00Inebilizumab 显著降低全身型重症肌无力加重与急救治疗需求：来自 III 期 MINT 试验的启示 https://news.medxy.ai/ja/generalized-myasthenia-gravis/Medxy AIja2026-08-14T08:11:58-07:00全身型重症筋無力症の増悪とレスキュー療法を大幅に抑制：第3相MINT試験からみたイネビリズマブの意義 https://news.medxy.ai/vi/inebilizumab-efficacy-myasthenia-gravis/Medxy AIvi2026-08-14T08:11:34-07:00Inebilizumab cho thấy hiệu quả vượt trội trong giảm đợt kịch phát và nhu cầu cứu hộ ở nhược cơ toàn thân: Kết quả từ thử nghiệm pha 3 MINT https://news.medxy.ai/inebilizumab-significantly-reduces-exacerbations-and-need-for-rescue-therapy-in-generalized-myasthenia-gravis-insights-from-the-phase-3-mint-trial/Medxy AIen2026-08-14T08:08:12-07:00Inebilizumab Significantly Reduces Exacerbations and Need for Rescue Therapy in Generalized Myasthenia Gravis: Insights from the Phase 3 MINT Trial https://news.medxy.ai/zh/liver-transplant-colorectal-cancer/Medxy AIzh2026-08-14T08:06:51-07:00结直肠癌不可切除肝转移的肝移植：SECA-II研究揭示长期生存与潜在治愈价值 https://news.medxy.ai/ja/liver-transplant-colon-cancer/Medxy AIja2026-08-14T08:06:34-07:00切除不能な大腸癌肝限局転移に対する肝移植の長期生存と根治可能性：SECA-II研究からの示唆 https://news.medxy.ai/vi/liver-transplant-colorectal-cancer-2/Medxy AIvi2026-08-14T08:06:14-07:00Ghép gan cho di căn gan do ung thư đại trực tràng không thể cắt bỏ: thời gian sống lâu dài và tiềm năng khỏi bệnh từ nghiên cứu SECA-II https://news.medxy.ai/long-term-survival-and-curative-potential-of-liver-transplantation-for-nonresectable-colorectal-liver-metastases-insights-from-the-seca-ii-study/Medxy AIen2026-08-14T08:04:54-07:00Long-Term Survival and Curative Potential of Liver Transplantation for Nonresectable Colorectal Liver Metastases: Insights from the SECA-II Study https://news.medxy.ai/zh/antiplatelet-use-after-ich/Medxy AIzh2026-08-14T08:04:37-07:00ICH 后能否用抗血小板药？STATICH 试验给出的风险与获益信号 https://news.medxy.ai/ja/antiplatelet-therapy-after-ich/Medxy AIja2026-08-14T08:04:11-07:00ICH後の抗血小板療法をどう考えるか：STATICH試験が示したリスクと利益の均衡 https://news.medxy.ai/vi/antiplatelet-therapy-risk-balance/Medxy AIvi2026-08-14T08:03:49-07:00Cân bằng nguy cơ: Điều trị kháng kết tập tiểu cầu sau xuất huyết nội sọ trong thử nghiệm STATICH https://news.medxy.ai/balancing-risks-antiplatelet-therapy-after-intracerebral-haemorrhage-in-the-statich-trial/Medxy AIen2026-08-14T08:02:21-07:00Balancing Risks: Antiplatelet Therapy After Intracerebral Haemorrhage in the STATICH Trial https://news.medxy.ai/zh/military-trauma-triage/Medxy AIzh2026-08-14T08:02:00-07:00军事创伤二元分诊系统简化评估：准确性与作战可行性的平衡 https://news.medxy.ai/ja/military-trauma-triage-2/Medxy AIja2026-08-14T08:01:32-07:00軍事外傷における簡略化二択トリアージの有用性を検証する：精度と運用実現性の両立 https://news.medxy.ai/vi/military-trauma-priority-classification/Medxy AIvi2026-08-14T08:01:04-07:00Đánh giá hệ thống phân loại ưu tiên nhị phân đơn giản hóa trong chấn thương quân sự: Cân bằng giữa độ chính xác và tính khả thi trong tác chiến https://news.medxy.ai/evaluating-a-simplified-binary-triage-system-for-military-trauma-balancing-accuracy-and-operational-feasibility/Medxy AIen2026-08-14T07:59:28-07:00Evaluating a Simplified Binary Triage System for Military Trauma: Balancing Accuracy and Operational Feasibility https://news.medxy.ai/zh/lung-cancer-surgery-range/Medxy AIzh2026-08-14T07:59:02-07:00非小细胞肺癌切除范围与切缘阳性的关系：手术范围并非决定因素 https://news.medxy.ai/ja/impact-resection-nsclc/Medxy AIja2026-08-14T07:58:46-07:00非小細胞肺癌における切除範囲の影響：断端陽性は術式に左右されない https://news.medxy.ai/vi/non-small-cell-lung-cancer/Medxy AIvi2026-08-14T07:58:24-07:00Ung thư phổi không tế bào nhỏ: bờ cắt dương tính không phụ thuộc phạm vi phẫu thuật https://news.medxy.ai/resection-extent-in-non-small-cell-lung-cancer-margin-positivity-is-unrelated-to-surgical-scope/Medxy AIen2026-08-14T07:57:10-07:00Resection Extent in Non-Small Cell Lung Cancer: Margin Positivity is Unrelated to Surgical Scope https://news.medxy.ai/zh/semaglutide-on-gestational-weight-gain-and-pregnancy-outcomes-in-obese-women/Medxy AIzh2026-08-14T07:56:47-07:00超重及肥胖女性暴露于司美格鲁肽对妊娠期体重增加及妊娠结局的影响 https://news.medxy.ai/ja/semaglutide-on-gestational-weight-gain-and-pregnancy-outcomes-in-overweight-and-obese-women/Medxy AIja2026-08-14T07:56:26-07:00過体重および肥満の女性におけるセマグルチド曝露が妊娠中の体重増加と妊娠転帰に及ぼす影響 https://news.medxy.ai/vi/semaglutide-pregnancy-weight/Medxy AIvi2026-08-14T07:56:04-07:00Phơi nhiễm semaglutide ảnh hưởng thế nào đến tăng cân thai kỳ và kết cục thai kỳ ở phụ nữ thừa cân, béo phì? https://news.medxy.ai/impact-of-semaglutide-exposure-on-gestational-weight-gain-and-pregnancy-outcomes-in-overweight-and-obese-women/Medxy AIen2026-08-14T07:54:13-07:00Impact of Semaglutide Exposure on Gestational Weight Gain and Pregnancy Outcomes in Overweight and Obese Women https://news.medxy.ai/zh/crohns-disease-additives/Medxy AIzh2026-08-14T07:53:51-07:00克罗恩病中人工甜味剂与乳化剂的新发现：来自 ENIGMA 研究的生物标志物与代谢机制 https://news.medxy.ai/ja/artificial-sweeteners-and-emulsifiers-in-crohns-disease/Medxy AIja2026-08-14T07:53:33-07:00クローン病における人工甘味料と乳化剤に関する新たな知見：ENIGMA研究から得られたバイオマーカーと代謝メカニズム https://news.medxy.ai/vi/crohns-food-additives/Medxy AIvi2026-08-14T07:53:12-07:00Bệnh Crohn và phụ gia thực phẩm: phát hiện mới về chất tạo ngọt nhân tạo, chất nhũ hóa và dấu ấn sinh học từ nghiên cứu ENIGMA https://news.medxy.ai/new-insights-into-artificial-sweeteners-and-emulsifiers-in-crohns-disease-biomarkers-and-metabolic-mechanisms-from-the-enigma-study/Medxy AIen2026-08-14T07:51:50-07:00New Insights into Artificial Sweeteners and Emulsifiers in Crohn’s Disease: Biomarkers and Metabolic Mechanisms from the ENIGMA Study https://news.medxy.ai/zh/cardiovascular-kidney-metabolic-syndrome-masld-fibrosis-risk/Medxy AIzh2026-08-14T07:51:28-07:00心血管—肾脏—代谢综合征与MASLD中肝纤维化进展及肝相关事件风险 https://news.medxy.ai/ja/masld-cardiovascular-renal-metabolic-syndrome/Medxy AIja2026-08-14T07:51:07-07:00MASLDにおける心血管・腎・代謝症候群と肝線維化進行・肝関連イベントへの影響 https://news.medxy.ai/vi/cardiorenal-metabolic-syndrome/Medxy AIvi2026-08-14T07:50:35-07:00Hội chứng tim mạch-thận-chuyển hóa và tác động của nó lên tiến triển xơ hóa gan cùng các biến cố liên quan đến gan trong MASLD https://news.medxy.ai/cardiovascular-kidney-metabolic-syndrome-and-its-impact-on-liver-fibrosis-progression-and-liver-related-events-in-masld/Medxy AIen2026-08-14T07:48:59-07:00Cardiovascular-Kidney-Metabolic Syndrome and Its Impact on Liver Fibrosis Progression and Liver-Related Events in MASLD https://news.medxy.ai/zh/daromun-melanoma/Medxy AIzh2026-08-13T22:03:02-07:00新辅助瘤内 Daromun 显著改善可切除 III 期黑色素瘤预后——PIVOTAL III 期试验更新解读 https://news.medxy.ai/ja/daromun-melanoma-2/Medxy AIja2026-08-13T22:02:43-07:00切除可能な第III期メラノーマに術前病変内Daromunが有望：PIVOTAL第III相試験更新で明らかになった効果 https://news.medxy.ai/vi/adjuvant-immunotherapy-melanoma/Medxy AIvi2026-08-13T22:02:18-07:00Daromun tân bổ trợ tiêm nội tổn thương cho thấy cải thiện rõ rệt kết cục ở u hắc tố giai đoạn III có thể cắt bỏ: cập nhật từ thử nghiệm pha III PIVOTAL https://news.medxy.ai/neoadjuvant-intralesional-daromun-significantly-improves-outcomes-in-resectable-stage-iii-melanoma-insights-from-the-pivotal-phase-iii-trial-update/Medxy AIen2026-08-13T22:01:06-07:00Neoadjuvant Intralesional Daromun Significantly Improves Outcomes in Resectable Stage III Melanoma: Insights from the PIVOTAL Phase III Trial Update https://news.medxy.ai/zh/age-prognosis-glioma/Medxy AIzh2026-08-13T21:52:16-07:00分子分型低级别胶质瘤中年龄作为预后指标的再评估 https://news.medxy.ai/ja/low-grade-glioma-age-prognosis/Medxy AIja2026-08-13T21:52:00-07:00分子病理で見直す低悪性度神経膠腫の年齢と予後 https://news.medxy.ai/vi/age-prognosis-low-grade-glioma/Medxy AIvi2026-08-13T21:51:38-07:00Xem xét lại vai trò của tuổi như một dấu ấn tiên lượng trong u thần kinh đệm độ thấp được xác định về mặt phân tử https://news.medxy.ai/reevaluating-age-as-a-prognostic-marker-in-molecularly-defined-lower-grade-gliomas/Medxy AIen2026-08-13T21:50:40-07:00Reevaluating Age as a Prognostic Marker in Molecularly Defined Lower-Grade Gliomas https://news.medxy.ai/zh/thyroid-nodule-sign/Medxy AIzh2026-08-13T18:28:31-07:00甲状腺结节周边间断点状强回声灶：高度提示乳头状甲状腺癌的新型超声征象 https://news.medxy.ai/vi/peripheral-microcalcifications/Medxy AIvi2026-08-13T18:28:04-07:00Các ổ tăng âm chấm nhỏ ngoại vi không liên tục: dấu ấn siêu âm mới gợi ý mạnh ung thư biểu mô tuyến giáp thể nhú https://news.medxy.ai/discontinuous-peripheral-punctate-echogenic-foci-a-novel-ultrasound-marker-highly-suggestive-of-papillary-thyroid-carcinoma/Medxy AIen2026-08-13T18:27:23-07:00Discontinuous Peripheral Punctate Echogenic Foci: A Novel Ultrasound Marker Highly Suggestive of Papillary Thyroid Carcinoma https://news.medxy.ai/zh/heart-failure-risk-diabetes-2/Medxy AIzh2026-08-13T18:27:04-07:00新诊断糖尿病中的心力衰竭风险：胰岛素抵抗与肾功能为何如此关键 https://news.medxy.ai/ja/unveiling-heart-failure-risks-in-newly-diagnosed-diabetes-insulin-resistance-and-renal-function/Medxy AIja2026-08-13T18:26:49-07:00新規診断された糖尿病における心不全リスクの解明：インスリン抵抗性と腎機能の重要な役割 https://news.medxy.ai/vi/heart-failure-risk-diabetes/Medxy AIvi2026-08-13T18:26:32-07:00Phát hiện nguy cơ suy tim ở người mới chẩn đoán đái tháo đường: Vai trò then chốt của đề kháng insulin và chức năng thận https://news.medxy.ai/unveiling-heart-failure-risks-in-newly-diagnosed-diabetes-the-critical-role-of-insulin-resistance-and-renal-function/Medxy AIen2026-08-13T18:25:50-07:00Unveiling Heart Failure Risks in Newly Diagnosed Diabetes: The Critical Role of Insulin Resistance and Renal Function https://news.medxy.ai/zh/vosoritide-growth-rasopathy/Medxy AIzh2026-08-13T18:25:32-07:00vosoritide 在 RASopathy 及相关遗传性矮身材患儿中显示出令人鼓舞的促生长作用 https://news.medxy.ai/ja/vosoritide-shows-growth-benefits-in-children-with-rasopathies-and-related-genetic-short-stature-disorders/Medxy AIja2026-08-13T18:25:16-07:00ヴォソリチド、RASopathies（ラスオパチー）および関連する遺伝性低身長症の小児において有望な成長促進効果を示す https://news.medxy.ai/vi/vosoritide-growth-benefits/Medxy AIvi2026-08-13T18:24:58-07:00Vosoritide cho thấy lợi ích tăng trưởng đầy hứa hẹn ở trẻ mắc RASopathy và các rối loạn thấp lùn di truyền liên quan https://news.medxy.ai/vosoritide-shows-promising-growth-benefits-in-children-with-rasopathies-and-related-genetic-short-stature-disorders/Medxy AIen2026-08-13T18:23:38-07:00Vosoritide Shows Promising Growth Benefits in Children with RASopathies and Related Genetic Short Stature Disorders https://news.medxy.ai/ja/gda-hba1c-correction/Medxy AIja2026-08-13T18:23:18-07:00CGM指標とHbA1cのずれを補正するGDAC研究：糖尿病診療に向けた個別化HbA1c補正の意義 https://news.medxy.ai/vi/personalized-hba1c-adjustment/Medxy AIvi2026-08-13T18:23:02-07:00Nghiên cứu GDAC về hiệu chỉnh HbA1c cá thể hóa dựa trên glucose: Cải thiện sự phù hợp giữa chỉ số từ CGM và HbA1c ở các cá thể và nhóm chủng tộc khác nhau mắc đái tháo đường, gợi ý cho thực hành lâm sàng https://news.medxy.ai/glucose-derived-personalized-hba1c-correction-gdac-study-to-improve-alignment-between-cgm-derived-metrics-and-hba1c-in-different-individuals-and-racial-groups-with-diabetes-implications-for-clinica/Medxy AIen2026-08-13T18:21:59-07:00Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice https://news.medxy.ai/zh/dynamic-metabolic-profiling-in-chronic-heart-failure/Medxy AIzh2026-08-13T18:21:41-07:00慢性心力衰竭中的动态代谢谱分析：基于连续核磁共振（NMR）生物标志物及风险预测的启示 https://news.medxy.ai/ja/chronic-heart-failure-metabolism/Medxy AIja2026-08-13T18:21:24-07:00慢性心不全における動的代謝プロファイリング：連続NMRバイオマーカーとリスク予測から得られた知見 https://news.medxy.ai/vi/metabolic-profiling-heart-failure/Medxy AIvi2026-08-13T18:21:05-07:00Lập hồ sơ chuyển hóa động trong suy tim mạn tính: Những phát hiện từ các dấu ấn sinh học NMR theo chuỗi thời gian và dự báo nguy cơ https://news.medxy.ai/dynamic-metabolic-profiling-in-chronic-heart-failure-insights-from-serial-nmr-biomarkers-and-risk-prediction/Medxy AIen2026-08-13T18:20:12-07:00Dynamic Metabolic Profiling in Chronic Heart Failure: Insights from Serial NMR Biomarkers and Risk Prediction https://news.medxy.ai/zh/oral-anticoagulants-cognition-and-clinical-outcomes-in-atrial-fibrillation-and-alzheimers-disease/Medxy AIzh2026-08-13T18:19:56-07:00房颤与阿尔茨海默病患者中的口服抗凝药、认知功能及临床结局的关联：一项瑞典全国性研究 https://news.medxy.ai/ja/afib-alzheimers-study/Medxy AIja2026-08-13T18:19:32-07:00心房細動とアルツハイマー病における経口抗凝固薬、認知機能、臨床転帰――スウェーデン全国規模研究が示す知見 https://news.medxy.ai/vi/oral-anticoagulants-alzheimers/Medxy AIvi2026-08-13T18:19:08-07:00Thuốc chống đông đường uống, nhận thức và kết cục lâm sàng ở rung nhĩ kèm bệnh Alzheimer: Những phát hiện từ một nghiên cứu toàn quốc tại Thụy Điển https://news.medxy.ai/oral-anticoagulants-cognition-and-clinical-outcomes-in-atrial-fibrillation-and-alzheimers-disease-insights-from-a-swedish-nationwide-study/Medxy AIen2026-08-13T18:17:08-07:00Oral Anticoagulants, Cognition, and Clinical Outcomes in Atrial Fibrillation and Alzheimer’s Disease: Insights from a Swedish Nationwide Study https://news.medxy.ai/ja/transthyretin-amyloid-cardiomyopathy/Medxy AIja2026-08-13T18:16:34-07:00トランスサイレチンアミロイド心筋症の疾患進行を捉え直す――機序特異的モニタリングと治療反応評価へ https://news.medxy.ai/vi/redefining-disease-progression/Medxy AIvi2026-08-13T18:16:13-07:00Tái định nghĩa tiến triển bệnh trong bệnh cơ tim amyloid transthyretin: Hướng tới theo dõi theo cơ chế và đánh giá đáp ứng điều trị https://news.medxy.ai/rethinking-disease-progression-in-transthyretin-amyloid-cardiomyopathy-toward-mechanism-specific-monitoring-and-therapeutic-response-assessment/Medxy AIen2026-08-13T18:15:31-07:00Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment https://news.medxy.ai/zh/enzyme-assay-hba2/Medxy AIzh2026-08-13T17:57:12-07:00酶学测定 2-羟基丁酸助力血糖异常筛查：超越传统空腹指标的新进展 https://news.medxy.ai/ja/dysglycemia-screening/Medxy AIja2026-08-13T17:56:56-07:00dysglycemiaスクリーニングを前進させる：2-ヒドロキシ酪酸の酵素測定が従来の空腹時指標を超える検出能を実現 https://news.medxy.ai/vi/2-hydroxybutyrate-test/Medxy AIvi2026-08-13T17:56:07-07:00Đo 2-Hydroxybutyrate bằng xét nghiệm enzym: Bước tiến mới trong sàng lọc rối loạn đường huyết vượt ngoài xét nghiệm lúc đói